Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is a prospective randomized clinical trial to compare the efficacy of the urinary and recombinant hCG on oocyte quality for ovulation induction in women undergoing IVF/ICSI.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Royan Institute
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• Indication for IVF/ICSI and Long Protocol ovarian stimulation

• Age 20-37

• Body mass index (BMI) ≤ 30 kg/m2

• Regular menstrual cycles of 25-35 days

• Tubal or male factor

• Existence of both ovary and normal uterine cavity

• Basal FSH≥10

• Physical health

Exclusion Criteria:

• Poly Cystic Ovarian Syndrome patients

• Contraindications of gonadotropins administration

• Poor response to ovulation induction in recent cycle